The aim of the present study was to determine the prevalence of long-term mucocele development after functional endoscopic sinus surgery (FESS) 
Introduction
Functional endoscopic sinus surgery (FESS) is now widely accepted in the setting of medical treatment failure in patients with nasal polyposis.
1,2 Nevertheless, the extent of surgery is still debated, ranging from polypectomy to radical ethmoidectomy. 3 In our experience, FESS has shown to be effective to control nasal polyp recurrence with good functional results. 4 Although the incidence of major and minor immediate complications of FESS have been well documented, 5, 6 only a few studies have documented long-term complications.
One of the most threatening scenarios after FESS is mucocele development because of the associated visual and neurologic risks. [7] [8] [9] This long-term complication can occur many years after surgery. 10, 11 Sinus or ethmoid cell obstruction after mucosal trauma and mucosal inflammation have an important pathophysiologic role in mucocele formation; [12] [13] [14] therefore, patients who undergo FESS for nasal polyposis might be at higher risk of postoperative mucocele.
Based on a retrospective analysis of 153 patients who underwent FESS for nasal polyposis with a minimum follow-up of 7 years, we aimed to: (1) determine the prevalence of long-term mucocele development, (2) search for potential statistical relationships with various variables, and (3) analyze the management and ultimate outcome of this long-term complication.
Patients and methods
Diagnostic criteria and patient selection. Our retrospective study included 153 patients with nasal polyposis who had failed medical treatment (twice-daily washing of the nasal cavities with sterile saline solution, twice daily intranasal beclomethasone spray in each nasal cavity, and oral steroid administration [i.e., prednisone, 1 mg/kg body weight per day for a 6-day period]). These patients were consecutively managed with FESS by the same physician (P.B.) from 1991 to 2008. FESS Benkhatar, khettaB, Sultanik, laccourreye, BonfilS was suggested to the patient if more than three systemic courses of prednisone per year had proved to be necessary to achieve a significant quality of life.
The initial diagnosis of nasal polyposis was based on two criteria: (1) the visualization of bilateral polyps in the nasal cavities on endoscopic examination, and (2) the existence of bilateral ethmoidal opaque areas on multislice computed tomography (CT) with a 1.25-mm slice thickness (120 Kv, 20 mA), located either in the anterior or the posterior ethmoid sinuses. The CT scan was performed at clinical baseline to obtain a reliable Lund-Mackay score. Table 1 presents the patients' preoperative variables. The severity of nasal polyposis was evaluated with a 4-point clinical scale (0 = no polyp; 1 = small polyps not reaching the lower edge of the middle turbinate; 2 = medium-sized polyps extending between the upper and lower edges of the inferior turbinate; and 3 = large polyps extending below the lower edge of the inferior turbinate).
Severity also was evaluated by calculating the Lund-Mackay score and searching for associated morbidities such as asthma, bronchial hyperreactivity after a challenge test with methacholine (performed for nonasthmatic patients according to the guidelines of the European Respiratory Society), 15 and aspirin or another nonsteroidal anti-inflammatory drug intolerance.
Patients with primary ciliary dyskinesia, ChurgStrauss syndrome, or cystic fibrosis were excluded from this study.
Initial surgical procedure and follow-up after initial FESS. The FESS procedure 4 was performed bilaterally with the assistance of computerized sinus navigation. It began with the inferior resection of the middle turbinate and fenestration of the maxillary antrum. Then, the posterior ethmoid cells were totally removed and the fovea ethmoidalis identified. The anterior ethmoid cells were also widely opened, and the frontal ostium was identified after Draf I sinusotomy. Mucosa of the frontal recess area was left untouched. A sphenoidotomy ended the procedure. Minimum length of follow-up was 7 years, with a mean of approximately 11 years (range: 7 to 21 years).
Postoperative clinical evaluation was conducted two to four times a year after FESS. At each visit, mean symptom severity, polyp size, and steroid consumption were evaluated. Regular sinus imaging (CT scan initially and cone-beam CT subsequently) was performed (with coronal, axial, and sagittal views) every 3 to 4 years after surgery and/or if clinical evaluation suggested potential development of a mucocele.
When a mucocele was suspected on sinus imaging (showing a well-delineated, cyst-like, homogeneous opacity with rounded bony outline and smooth bone erosion), magnetic resonance imaging (MRI) was implemented to confirm the diagnosis or to study the surrounding orbit and brain. MRI showed different patterns of T1-weighted signals (from low T1 in young mucoceles to high T1 in older mucoceles) and a high T2 signal, associated with a thin mucosal lining.
Frontal sinus mucoceles were classified according to Sama's classification: medial, intermediate, and lateral. 16 Endoscopic marsupialization of the mucocele was performed in patients with symptoms or, in asymptomatic patients, if erosion of the orbital walls or skull base was found on imaging.
Statistical analysis. Statistical analysis searched for a potentially significant relation between this long-term complication and the variables depicted in table 1. The prognostic value of each variable was analyzed using a Cox model, adjusted with time between surgery and complication (in cases of multiple surgeries for this complication in the same patient, only the first event was included). Univariate and multivariate analyses were performed.
Survival curves were determined using the median of continuous variables as a distinction threshold between groups. A log-rank test was performed to analyze the difference between groups. Statistical significance was set at the bilateral p value = 0.05. Statistical analysis used the Statistical Package for the Social Sciences software ver. 20.0 for Macintosh.
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Benkhatar, khettaB, Sultanik, laccourreye, BonfilS were asymptomatic, with mucoceles being discovered on sinus imaging during follow-up (table 2) . Five patients (25%) were symptomatic, with mucoceles causing facial pain in 8 cases, proptosis in 3 cases, and diplopia in 2 cases (each of the 5 patients had multiple mucoceles in different locations).
The mean delay between the initial procedure and this complication was 75 months (6.25 years), ranging from 11 months to 16.5 years. Among the 39 diagnosed mucoceles, frontal and anterior ethmoid mucoceles were predominant (61.5%). Strictly frontal mucoceles were medial in 3 cases, intermediate in 1 case, and lateral in 1 case. Other mucoceles developed in the posterior ethmoid (28.2%), the sphenoid (7.7%) and, rarely, in the maxillary sinus (2.6%).
Potential statistical relationship with various variables. In univariate and multivariate analysis, the preoperative Lund-Mackay score was the only variable that significantly Benkhatar, khettaB, Sultanik, laccourreye, BonfilS indicated an increased risk for mucocele development (p = 0.04). Asthma and aspirin intolerance were not associated with an increased risk of mucocele development.
Management of mucoceles and outcomes. As mentioned above, 28 procedures for 39 mucoceles were performed in 20 patients (table 2) . Endoscopic marsupialization of the mucocele into the nasal cavity (made as large as the anatomy allowed and helped by the navigation system) was performed for 19 patients (26 procedures).
One of the 39 operated mucoceles recurred (for a recurrence rate of 2.7%); the mucocele was in the frontal sinus. The patient with this recurrence had first presented with an intermediate frontal mucocele and contralateral frontal recess stenosis; at that time, a Draf III procedure was undertaken. Almost 4 years later, he presented with a recurrence of that mucocele with an associated medial frontal mucocele on the opposite side. The frontal sinusotomy was closed by scar tissue and was reopened to gain access to both mucoceles. One-week stenting with a Silastic sheet was implemented. To date, this patient has not required another revision surgery.
One patient presenting with frontal mucoceles required surgery via external approaches. First, he presented with a medial frontal mucocele and Kuhn type 4 cell, which required additional sinus trephination through an eyebrow incision. One-week stenting with a Silastic sheet was implemented. Two years later, he presented with a lateral frontal mucocele (with complete closure of the frontal ostium by neo-osteogenesis) on the same side, and therefore a frontal sinus obliteration procedure (with abdominal fat) was performed. To date, this patient has not required another revision surgery.
Facial pain and ophthalmic symptoms disappeared in all symptomatic cases.
Discussion
Prevalence of mucocele development. During the decades since the introduction of FESS, post-FESS mucoceles have been increasingly reported. 17, 18 Most cases of chronic rhinosinusitis have non-evolving pathologies, with no persisting mucosal inflammation after FESS (e.g., sinus fungus ball). In nasal polyposis, the mucosa remains inflammatory with subsequent recurrent polyps. The persistent inflammation modifies the postoperative follow-up and may increase the risk of mucocele development.
The strength of the present study is the large number of patients (153 consecutive patients) with a similar disease and long-term follow-up (mean >11 years).
Mucocele development was noted in 20 patients (13.1%). This rate is higher than those reported in previous studies: 0%, 19,20 2.5%, 21 and 2.6% 22 after FESS procedures for patients with nasal polyposis (table 3) . However, these publications reported a shorter follow-up, with a mean of 3 years. [19] [20] [21] [22] In our study, the minimum follow-up was 7 years and the mean delay between the initial procedure and the mucocele diagnosis was 75 months (more than 6 years).
Previous publications only reported rates of symptomatic mucoceles. [17] [18] [19] [20] [21] [22] Since fiberendoscopy is unlikely to detect early intrasinus mucoceles, and asymptomatic mucoceles can only be detected after surgery by regular sinus imaging, previous studies might have underestimated the real proportion of mucoceles.
Given the prevalence of asymptomatic mucoceles, regular sinus imaging should be considered after nasal polyposis surgery in selected patients. However, radiologic screening can be associated with a significant cost and a risk of radiation exposure. Our findings led us to prefer the use of cone-beam CT to significantly reduce Benkhatar, khettaB, Sultanik, laccourreye, BonfilS the radiation exposure, and to limit its use as a mucocele screening tool only for (1) symptomatic patients presenting with headache, facial pressure, or orbital symptoms and (2) asymptomatic patients with abnormal findings on clinical examination (frontal swelling, endonasal bulge on endoscopic examination, recurrent polyps). Additionally, increased watchfulness may be necessary during the follow-up in patients with a high preoperative Lund-Mackay score (>19) or a previous history of mucoceles.
Risk factors for mucocele development. Our study demonstrated that a high preoperative Lund-Mackay score was an independent risk factor for mucocele development. To our knowledge, there is no other study reporting a significant risk factor. A higher Lund-Mackay score is related to lower sinonasal mucociliary clearance, leading to a higher grade of sinus opacification.
In cases of nasal polyposis, mucociliary dysfunction is mainly caused by inflammation, which induces excessive mucin production (leading to highly viscoelastic mucus and mucostasis), rather than ciliary cell impairment. [23] [24] [25] This fact agrees with prevailing theories of mucocele development that include obstruction and inflammation. [12] [13] [14] In addition, cytokines such as IL-1β and TNF-α can induce both mucin production and bone resorption. 14, 25, 26 Therefore, this suggests that in cases of surgically induced mucosal entrapment, the higher the patient's inflammatory responsiveness, the higher the level of mucin production and bone resorption. This mechanism could explain the higher risk of mucocele development in severe nasal polyposis.
As previously suggested, the preponderance of frontoethmoid mucocele may be related to the fact that mucosal contacts are more likely to happen in narrow areas.
14 According to these findings, preoperative oral steroid therapy, which reduces polyp size before surgery and increases visibility during FESS, 27 could theoretically help to achieve a better sinus opening and reduce the risk of short-term ostial stenosis (particularly in the frontal recess area) and long-term mucocele development. Consequently, we prescribe a 5-day course of prednisone (1 mg/kg) before surgery.
In our study, asthma and aspirin intolerance were not associated with this complication. Some studies showed that the number of eosinophils in patients with the Samter triad was four times higher than in patients with nasal polyposis and asthma alone, and 15 times higher than in patients with nasal polyposis alone. 28, 29 Consequently, we suggest that eosinophils may not have an important role in mucocele formation, whereas lymphocytes and monocytes appeared to be involved in that process. 13 Moreover, recent studies suggest that eosinophils infiltrating the periosteum are more likely to promote osteoblastic activity and neo-ostegenesis in patients with nasal polyposis.
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Management of mucoceles. In our study, 39 mucoceles were managed in 20 patients. Endoscopic marsupialization was achieved for 37 mucoceles (19 patients) with only 1 case of recurrent medial frontal mucocele (recurrence rate of 2.7%). This result agrees with other series that described low recurrence rates after endoscopic mucocele marsupialization, ranging from 0% with a mean follow-up of 17.6 months 31 to 0.9% with a mean follow-up of 4.6 years. 17 A large series also showed a recurrence rate of 1.6% after microendoscopic mucocele marsupialization, with a median follow-up of 12 years. 18 According to the literature, it is not necessary to attempt to repair bone defects caused by mucoceles. 11, 16, 18 In fact, a recent study demonstrated a possible reversal of the bone resorption process over years, i.e., complete self-regeneration of the eroded bone. 32 Interestingly, it is possible that pro-osteoblastic medical treatments such as vitamin D supplementation might ease bone regeneration, as vitamin D deficiency is more frequently encountered in patients with nasal polyposis than in the general population. 33 In our study, one patient required external surgical approaches for two frontal mucoceles. As suggested by a recent series, external approaches are still a part of the surgeon's armamentarium in the treatment of frontal mucoceles, especially in cases of lateral frontal mucoceles or extensive frontal ostium neo-osteogenesis. 16 Extended endoscopic frontal sinusotomies (Draf IIa to III) are effective in cases of medial or intermediate frontal mucocele, limited frontal drainage pathway, and/or associated type III/IV frontoethmoid cells. 16 These difficult cases highlight the need to properly inform patients about the long-term risk of mucocele development after nasal polyposis surgery.
Conclusion
This article presents a study of mucocele development after FESS for nasal polyposis in a large cohort of 153 patients with a mean follow-up of approximately 11 years. This complication occurred in a significant number of patients (13.1%), and the mean delay between the initial procedure and the mucocele diagnosis was about 6 years, with almost 40% of the mucoceles being asymptomatic and diagnosed on sinus imaging. A high preoperative Lund-Mackay score (>19) was correlated with a higher risk of mucocele development (p = 0.04).
Endoscopic marsupialization is the standard of treatment and is associated with a low recurrence rate, but frontal mucocele treatment remains challenging and may require advanced techniques, such as extended endoscopic frontal sinusotomy or an external approach.
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These findings stress the importance of a prolonged clinical evaluation of any patient undergoing FESS for nasal polyposis. In our opinion, systematic radiologic screening is not to be recommended to detect mucoceles, given the cost of unnecessary exams and the radiation exposure risk (although it is significantly reduced by using cone-beam CT). Nevertheless, increased watchfulness may be necessary during the follow-up in patients with a high preoperative Lund-Mackay score (>19) or a history of mucoceles.
Any patient undergoing FESS for nasal polyposis must be informed of the long-term risk of mucocele development that can lead to intraorbital or intracranial complications, and occasionally difficult revision surgeries.
